ADSCC reports promising results in diabetes management using UC-MSC therapy

Diabetes, the relentless global health challenge, may have just met its match. A groundbreaking milestone in the fight against type 1 diabetes has emerged from the heart of the UAE...

The Abu Dhabi Stem Cells Centre (ADSCC) recently revealed remarkable progress using umbilical cord-derived mesenchymal stem cells (UC-MSCs). This innovation could reshape the lives of millions grappling with this chronic condition.

One Emirati youth, aged 20, is already reaping the benefits of this pioneering treatment, with his health transforming mere weeks after the procedure.

How does it work?

Think of UC-MSC therapy as a cellular symphony, where advanced science orchestrates healing. At ADSCC's state-of-the-art laboratories, stem cells are carefully harvested from umbilical cords and cultivated to perfection. These cells are then administered intravenously during a meticulously monitored two-hour session. The multidisciplinary team ensures every detail — from dosage to infusion — aligns with strict protocols and quality controls.

"Our GMP laboratories and cellular manufacturing infrastructure empower us to deliver cutting-edge treatments," said Dr. Antonio Bencomo, General Manager of ADSCC Research Centre.

The therapy's immediate results include better blood sugar levels and reduced diabetes-related antibodies. Over time, these improvements hint at rejuvenating pancreatic function and reduced insulin dependency.

Why does it matter?

For millions living with type 1 diabetes, this breakthrough is a beacon of hope. Picture a world where insulin shots are no longer daily rituals. The ADSCC's stem cell therapy promises safer, more sustainable disease management. Notably, the Emirati patient exhibited no side effects during the trial, underscoring the treatment's safety profile.

Dr. Maysoon Al Karam, Chief Medical Officer at ADSCC, expressed the broader implications: "This milestone is a testament to our commitment to innovation. Our work doesn't just improve lives; it sets the stage for Abu Dhabi to lead in novel medical treatments."

The therapy's potential isn't confined to type 1 diabetes. ADSCC is already exploring its application for type 2 diabetes, signaling a future where this chronic condition is manageable on a global scale.

The context

In an era when chronic diseases burden healthcare systems worldwide, this development positions Abu Dhabi as a vanguard of medical progress. Stem cell research has long been the stuff of scientific dreams, but ADSCC's achievement transforms it into a practical, life-changing reality. Their multidisciplinary approach and investment in GMP-certified facilities have carved a niche for the UAE in regenerative medicine.

"This discovery places Abu Dhabi at the forefront of novel medical treatments in the region," Dr. Al Karam added. By focusing on cellular innovations, ADSCC isn't just treating diseases; it's rewriting the playbook for chronic care.

For the Emirati patient and countless others worldwide, the message is clear: the fight against diabetes has turned a promising corner. ADSCC's vision is one of hope, science, and transformative care — proof that innovation and perseverance can change lives.